GlassScriptPhysician profile
Matthew D Stover
NPI 1649412578
$10,016.05
in general payments reported to CMS, 2019-2025
26 companies · $15.93 in 2025
The $15.93 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,443 · 2020: $381 · 2021: $730 · 2022: $3,074 · 2023: $899 · 2024: $473 · 2025: $15.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,092 · Education: $296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,092.45 |
| Education | $295.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mid-Atlantic Surgical Systems, LLC | $3,654.85 | 2019-2024 | |
| Zimmer Biomet Holdings, INC. | $2,339.46 | 2019-2024 | Rosa, Comprehensive Shoulder System, Persona |
| Arthrex, INC. | $2,158.00 | 2019 | |
| Abbott Laboratories | $681.23 | 2019-2025 | Proclaim |
| Stryker Corporation | $241.60 | 2019-2022 | |
| Organogenesis INC. | $206.95 | 2023 | Puraply |
| Bioventus LLC | $132.96 | 2019-2024 | Exogen Ultrasound Bone Healing System, Durolane |
| Smith+Nephew, INC. | $77.54 | 2021-2024 | Pico 7, Evos |
| Vericel Corporation | $73.80 | 2020-2021 | |
| Orthofix Medical, INC. | $50.46 | 2019-2020 | |
| Pacira Therapeutics, INC. | $47.51 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $43.03 | 2023-2024 | Exparel, Iovera, Zilretta |
| Treace Medical Concepts, INC. | $41.50 | 2022 | |
| Ferring Pharmaceuticals INC. | $39.71 | 2019-2021 | |
| Convatec INC. | $29.52 | 2023-2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $22.92 | 2019 | |
| Medela LLC | $22.54 | 2020 | |
| Endo Pharmaceuticals INC. | $22.18 | 2022 | |
| Linvatec Corporation | $21.40 | 2021 | |
| Kci USA, INC. | $18.35 | 2023 | Prevena, Promogran Prisma, Activ.A.C. |
| Encore Medical, LP | $17.39 | 2023 | Djo Surgical |
| Pfizer INC. | $16.85 | 2019 | |
| Nevro Corp. | $14.62 | 2024 | Senza |
| Davol INC. | $14.44 | 2021 | |
| Sonex Health, INC. | $13.67 | 2020 | |
| Heron Therapeutics, INC. | $13.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Stover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.